• Showing all 7 results

  • Blinatumomab

    Description:
    Analog to the therapeutic Blinatumomab, also known as Blincyto. Blinatumomab is a  BiTE directed to CD3 and CD19.
    Cat. No.
    AB-BLINA
  • View product
  • Ivonescimab

    Description:
    Analog to the therapeutic Ivonescimab, an bispecific antibody directed to PD-1 and VEGF.
    Cat. No.
    AB-IVON
  • View product
  • Pembrolizumab

    Description:
    Analog to the therapeutic antibody Pembrolizumab, directed to PD-1 protein.  
    Cat. No.
    AB-PEMBRO
  • View product

Custom services

Contact us for a free consultation or if you need a quote